EA200901059A1 - Макролиды на основе эритромицина - Google Patents

Макролиды на основе эритромицина

Info

Publication number
EA200901059A1
EA200901059A1 EA200901059A EA200901059A EA200901059A1 EA 200901059 A1 EA200901059 A1 EA 200901059A1 EA 200901059 A EA200901059 A EA 200901059A EA 200901059 A EA200901059 A EA 200901059A EA 200901059 A1 EA200901059 A1 EA 200901059A1
Authority
EA
Eurasian Patent Office
Prior art keywords
macrolides
erythromycin
basis
compounds
formula
Prior art date
Application number
EA200901059A
Other languages
English (en)
Inventor
Ричард Аллен ст. Бузон
Марк Эдвард Флэнаган
Женгонг Брайан Ли
Томас Виктор Маги
Марк Карл Ноу
Юса Датта Рейлли
Дэниел Уилльям Видлика
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of EA200901059A1 publication Critical patent/EA200901059A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Изобретение относится к соединениям формулы (I), где R, Rи Х являются такими, как определено в описании. Изобретение также относится к фармацевтическим композициям и способам лечения бактериальных инфекций, в которых используют соединения формулы (I).
EA200901059A 2007-03-13 2008-03-04 Макролиды на основе эритромицина EA200901059A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89447507P 2007-03-13 2007-03-13
US2337008P 2008-01-24 2008-01-24
PCT/IB2008/000715 WO2008110918A2 (en) 2007-03-13 2008-03-04 Erythromycin-based macrolides

Publications (1)

Publication Number Publication Date
EA200901059A1 true EA200901059A1 (ru) 2010-02-26

Family

ID=39760163

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200901059A EA200901059A1 (ru) 2007-03-13 2008-03-04 Макролиды на основе эритромицина

Country Status (28)

Country Link
US (1) US20080293646A1 (ru)
EP (1) EP2125851B1 (ru)
JP (1) JP4468487B1 (ru)
KR (1) KR20090110381A (ru)
CN (1) CN101631795A (ru)
AP (1) AP2009004985A0 (ru)
AR (1) AR065724A1 (ru)
AT (1) ATE471943T1 (ru)
AU (1) AU2008224633A1 (ru)
BR (1) BRPI0809002A2 (ru)
CA (1) CA2680527A1 (ru)
CL (1) CL2008000695A1 (ru)
CR (1) CR10998A (ru)
CU (1) CU20090155A7 (ru)
DE (1) DE602008001611D1 (ru)
DO (1) DOP2009000214A (ru)
EA (1) EA200901059A1 (ru)
EC (1) ECSP099627A (ru)
IL (1) IL200613A0 (ru)
MA (1) MA31252B1 (ru)
MX (1) MX2009009074A (ru)
PA (1) PA8772401A1 (ru)
PE (1) PE20090106A1 (ru)
SV (1) SV2009003368A (ru)
TN (1) TN2009000374A1 (ru)
TW (1) TW200848061A (ru)
UY (1) UY30957A1 (ru)
WO (1) WO2008110918A2 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2822953T5 (en) * 2012-03-06 2017-09-11 Pfizer Macrocyclic derivatives for the treatment of proliferative diseases
KR102363621B1 (ko) 2013-04-04 2022-02-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 매크롤라이드 그리고 그의 제조방법 및 용도
WO2016057798A1 (en) 2014-10-08 2016-04-14 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
US10640528B2 (en) 2015-03-25 2020-05-05 President And Fellows Of Havard College Macrolides with modified desosamine sugars and uses thereof
CN105924451B (zh) * 2016-04-27 2017-12-15 国家海洋局第三海洋研究所 具有抗茶叶致病真菌活性的大环内酯化合物及制备与用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2233493A1 (en) * 2004-12-21 2010-09-29 Pfizer Products Inc. Macrolides

Also Published As

Publication number Publication date
EP2125851A2 (en) 2009-12-02
MA31252B1 (fr) 2010-03-01
JP4468487B1 (ja) 2010-05-26
UY30957A1 (es) 2008-10-31
PE20090106A1 (es) 2009-02-08
AU2008224633A1 (en) 2008-09-18
CR10998A (es) 2009-09-11
SV2009003368A (es) 2009-11-09
KR20090110381A (ko) 2009-10-21
AP2009004985A0 (en) 2009-10-31
DOP2009000214A (es) 2009-10-31
TW200848061A (en) 2008-12-16
BRPI0809002A2 (pt) 2014-11-11
IL200613A0 (en) 2010-05-17
ATE471943T1 (de) 2010-07-15
CA2680527A1 (en) 2008-09-18
WO2008110918A2 (en) 2008-09-18
PA8772401A1 (es) 2008-11-19
WO2008110918A3 (en) 2009-01-29
AR065724A1 (es) 2009-06-24
TN2009000374A1 (fr) 2010-12-31
MX2009009074A (es) 2009-09-28
ECSP099627A (es) 2009-10-30
CN101631795A (zh) 2010-01-20
DE602008001611D1 (en) 2010-08-05
CU20090155A7 (es) 2011-04-26
EP2125851B1 (en) 2010-06-23
US20080293646A1 (en) 2008-11-27
CL2008000695A1 (es) 2008-09-22
JP2010521448A (ja) 2010-06-24

Similar Documents

Publication Publication Date Title
DK2164331T3 (da) Borholdige små molekyler
CY1116383T1 (el) Αντιβακτηριακες ενωσεις
WO2008115281A3 (en) Compounds for treating viral infections
EA201170772A1 (ru) Органические соединения
SG178952A1 (en) Chemical compounds
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
EA201100299A1 (ru) Органические соединения
EA201200323A1 (ru) Соединения и композиции, как ингибиторы протеинкиназы
TW200734344A (en) Antibacterial agents
ATE472529T1 (de) Prolinamidderivate als natriumkanalmodulatoren
WO2006120563A3 (en) Antibacterial agents
AU2007249926A8 (en) Monocyclic heteroaryl compounds
EA201190095A1 (ru) Производные актагардина
WO2010151784A3 (en) Antimicrobial compounds
PA8855001A1 (es) Monocarbamas
EA201490435A1 (ru) Антибактериальные 3,4-дигидро-1н-[1,8]нафтиридиноны, замещенные пиперидинилом
EA201490436A1 (ru) Антибактериальные 3,4-дигидро-1н-[1,8]нафтиридиноны, замещенные гомопиперидинилом
EA200901059A1 (ru) Макролиды на основе эритромицина
CY1110971T1 (el) Τοπικη αντιβιοτικη συνθεση για την προληψη της νοσου lyme
MX337145B (es) Composiciones farmaceuticas.
MX2012003411A (es) Composiciones y metodos para tratar infecciones bacterianas utilizando ceftarolina.
CY1112684T1 (el) 3-κυανοπυρρολιδινυλ-φαινυλ-οξαζολιδινονες ως αντιβακτηριδιακα μεσα
FR2907121B1 (fr) Nouveaux derives morphiniques
CL2008003758A1 (es) Compuestos derivados de 1(2)h-tetrazol-5-il-fenil-oxazolidinonas, procedimiento de preparacion, composicion farmaceutica, util para el tratamiento de infecciones bacterianas.
CL2010001590A1 (es) Compuestos derivados de 3-(n-heterociclil)-pirrolidin-feniloxazolidinonas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto para el tratamiento de infecciones bacterianas